Stacy L. Taylor - Dec 22, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
SVP and General Counsel
Signature
/s/ Stacy L. Taylor by Eric Billings as attorney-in-fact
Stock symbol
ADPT
Transactions as of
Dec 22, 2021
Transactions value $
-$353,166
Form type
4
Date filed
12/23/2021, 08:00 PM
Previous filing
Sep 9, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $66.4K +10.1K +67.37% $6.55 25.2K Dec 22, 2021 Direct F1
transaction ADPT Common Stock Options Exercise $40.6K +5.21K +20.69% $7.80 30.4K Dec 22, 2021 Direct F1
transaction ADPT Common Stock Sale -$460K -15.3K -50.5% $30.00 15K Dec 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -10.1K -65.6% $0.00 5.31K Dec 22, 2021 Common Stock 10.1K $6.55 Direct F1, F2
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -5.21K -22.73% $0.00 17.7K Dec 22, 2021 Common Stock 5.21K $7.80 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2021.
F2 The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.
F3 The options vested with respect to 1/4 of such shares on April 23, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.